Metropolis Healthcare (NSE:METROPOLIS, BOM:542650) has incorporated a wholly-owned subsidiary named Metropolis Clinical Pathology, according to a Wednesday filing to the stock exchanges.
The new subsidiary aims to provide all kinds of diagnostic services, the filing said.
Price (INR): ₹1988.90, Change: ₹-25, Percent Change: -1.23%